English
Home > Products > Liranaftate API

China Liranaftate API Factory

Dedicated to strict top quality command and considerate purchaser support, our experienced staff customers are always available to discuss your necessities and be certain full client gratification for Liranaftate API,CAS NO 88678-31-3,88678-31-3, We're on the lookout ahead to receiving your enquiries soon.
Liranaftate API, Our goods have been obtained more and more recognition from foreign clients, and established long term and cooperative relationship with them. We`ll offer the best service for every customer and sincerely welcome friends to work with us and establish the mutual benefit together.

Related Products

Hot Products

  • bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate

    bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate

    Product Name:bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate
    Molecular Formula:C26H24Cl6O8
    Molecular Weight:677.18
    CAS Registry Number:30431-54-0
  • 2-Isopropyl-4-(methylaminomethyl)thiazole

    2-Isopropyl-4-(methylaminomethyl)thiazole

    Product Name:2-Isopropyl-4-(methylaminomethyl)thiazole
    Molecular Formula:C8H14N2S
    Molecular Weight:170.28
    CAS Registry Number:154212-60-9
  • N-Boc-L-tert-Leucine

    N-Boc-L-tert-Leucine

    Product Name:N-Boc-L-tert-Leucine
    Molecular Formula:C11H21NO4
    Molecular Weight:231.29
    CAS Registry Number:62965-35-9
  • 2-Bromo-2'-chloroacetophenone

    2-Bromo-2'-chloroacetophenone

    Product Name:2-Bromo-2'-chloroacetophenone
    Molecular Formula:C8H6BrClO
    Molecular Weight:233.49
    CAS Registry Number:5000-66-8
  • 1,3-Dioxo-2-isoindolineaceticacid

    1,3-Dioxo-2-isoindolineaceticacid

    Product Name:1,3-Dioxo-2-isoindolineaceticacid
    Molecular Formula:C10H7NO4
    Molecular Weight:205.17
    CAS Registry Number:6296-53-3
  • Everolimus

    Everolimus

    Product Name:Everolimus
    Molecular Formula:C53H83NO14
    Molecular Weight;958.22
    CAS Registry Number;159351-69-6
  • Related Blog
  • Reviews

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept